FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019320625> ?p ?o ?g. }

• W2019320625 endingPage "130.e1" @default.
• W2019320625 startingPage "124" @default.
• W2019320625 abstract "BackgroundStudies examining the asthma-related risks of cardiovascular disease (CVD) events have generally used selected samples or did not control for the effects of β2-agonist use, itself associated with CVD events.ObjectivesWe assessed the relationship between incident CVD/stroke and asthma and the effect of atopy while controlling for β2-agonist use in a representative adult population cohort free of CVD at baseline.MethodsThe North West Adelaide Health Study (stage 1, n = 3812; stage 2, n = 3113) assessed spirometry, anthropometry, atopy, blood pressure, and lipid levels. Questionnaires assessed doctor-diagnosed asthma and CVD (myocardial infarction and angina)/stroke, smoking status, and demographics. Asthma was defined by self-report or FEV1 reversibility. Current short- and long-acting β2-agonist use was identified at follow-up.ResultsResults are expressed as odds ratios (ORs) and 95% CIs. By using multivariable logistic regression, after adjustment for risk factors, in female subjects incident CVD/stroke events were associated with asthma (OR, 3.24; 95% CI, 1.55-6.78), with no effect modification by atopy (P for interaction = .61), and with as-required short-acting β2-agonist use (OR, 2.66; 95% CI, 1.06-6.61). In male subjects events were associated with daily cough/sputum (OR, 1.92; 95% CI, 1.05-3.50) and FEV1 of less than 80% of predicted value but an FEV1/forced vital capacity ratio of greater than 0.70 (OR, 2.15; 95% CI, 0.91-5.09; P = .08). Although few CVD/stroke events occurred in male subjects with asthma, a significant interaction with atopic status was found (P = .05).ConclusionsStudies are required to elucidate how asthma exposes older women to excess macrovascular risk and prospectively determine the short-acting β2-agonist–related risk in persons without existing CVD. CVD risk in relation to atopic status of asthma also requires further investigation. Studies examining the asthma-related risks of cardiovascular disease (CVD) events have generally used selected samples or did not control for the effects of β2-agonist use, itself associated with CVD events. We assessed the relationship between incident CVD/stroke and asthma and the effect of atopy while controlling for β2-agonist use in a representative adult population cohort free of CVD at baseline. The North West Adelaide Health Study (stage 1, n = 3812; stage 2, n = 3113) assessed spirometry, anthropometry, atopy, blood pressure, and lipid levels. Questionnaires assessed doctor-diagnosed asthma and CVD (myocardial infarction and angina)/stroke, smoking status, and demographics. Asthma was defined by self-report or FEV1 reversibility. Current short- and long-acting β2-agonist use was identified at follow-up. Results are expressed as odds ratios (ORs) and 95% CIs. By using multivariable logistic regression, after adjustment for risk factors, in female subjects incident CVD/stroke events were associated with asthma (OR, 3.24; 95% CI, 1.55-6.78), with no effect modification by atopy (P for interaction = .61), and with as-required short-acting β2-agonist use (OR, 2.66; 95% CI, 1.06-6.61). In male subjects events were associated with daily cough/sputum (OR, 1.92; 95% CI, 1.05-3.50) and FEV1 of less than 80% of predicted value but an FEV1/forced vital capacity ratio of greater than 0.70 (OR, 2.15; 95% CI, 0.91-5.09; P = .08). Although few CVD/stroke events occurred in male subjects with asthma, a significant interaction with atopic status was found (P = .05). Studies are required to elucidate how asthma exposes older women to excess macrovascular risk and prospectively determine the short-acting β2-agonist–related risk in persons without existing CVD. CVD risk in relation to atopic status of asthma also requires further investigation." @default.
• W2019320625 created "2016-06-24" @default.
• W2019320625 creator A5001591986 @default.
• W2019320625 creator A5019816563 @default.
• W2019320625 creator A5020185605 @default.
• W2019320625 creator A5024243963 @default.
• W2019320625 creator A5037128174 @default.
• W2019320625 date "2009-01-01" @default.
• W2019320625 modified "2023-09-26" @default.
• W2019320625 title "Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting β2-agonists" @default.
• W2019320625 cites W1570824340 @default.
• W2019320625 cites W1947569095 @default.
• W2019320625 cites W1972256232 @default.
• W2019320625 cites W1976282279 @default.
• W2019320625 cites W1981444005 @default.
• W2019320625 cites W1981479649 @default.
• W2019320625 cites W1982654896 @default.
• W2019320625 cites W1982732664 @default.
• W2019320625 cites W1989690082 @default.
• W2019320625 cites W2008781815 @default.
• W2019320625 cites W2013112027 @default.
• W2019320625 cites W2023221852 @default.
• W2019320625 cites W2026731374 @default.
• W2019320625 cites W2046296361 @default.
• W2019320625 cites W2051506133 @default.
• W2019320625 cites W2054008298 @default.
• W2019320625 cites W2059101530 @default.
• W2019320625 cites W2061861931 @default.
• W2019320625 cites W2067523691 @default.
• W2019320625 cites W2071653242 @default.
• W2019320625 cites W2079974164 @default.
• W2019320625 cites W2094354458 @default.
• W2019320625 cites W2096721824 @default.
• W2019320625 cites W2097141656 @default.
• W2019320625 cites W2100907993 @default.
• W2019320625 cites W2103288679 @default.
• W2019320625 cites W2103790323 @default.
• W2019320625 cites W2103916194 @default.
• W2019320625 cites W2118244600 @default.
• W2019320625 cites W2123626351 @default.
• W2019320625 cites W2125266996 @default.
• W2019320625 cites W2126233278 @default.
• W2019320625 cites W2126695120 @default.
• W2019320625 cites W2132337491 @default.
• W2019320625 cites W2133569818 @default.
• W2019320625 cites W2134122420 @default.
• W2019320625 cites W2141642131 @default.
• W2019320625 cites W2144379053 @default.
• W2019320625 cites W2146396970 @default.
• W2019320625 cites W2148101681 @default.
• W2019320625 cites W2158079900 @default.
• W2019320625 cites W2160103886 @default.
• W2019320625 cites W2169360280 @default.
• W2019320625 cites W2410020615 @default.
• W2019320625 cites W3129177 @default.
• W2019320625 cites W4249200669 @default.
• W2019320625 doi "https://doi.org/10.1016/j.jaci.2008.10.032" @default.
• W2019320625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19130933" @default.
• W2019320625 hasPublicationYear "2009" @default.
• W2019320625 type Work @default.
• W2019320625 sameAs 2019320625 @default.
• W2019320625 citedByCount "38" @default.
• W2019320625 countsByYear W20193206252012 @default.
• W2019320625 countsByYear W20193206252013 @default.
• W2019320625 countsByYear W20193206252014 @default.
• W2019320625 countsByYear W20193206252015 @default.
• W2019320625 countsByYear W20193206252016 @default.
• W2019320625 countsByYear W20193206252017 @default.
• W2019320625 countsByYear W20193206252018 @default.
• W2019320625 countsByYear W20193206252019 @default.
• W2019320625 countsByYear W20193206252020 @default.
• W2019320625 countsByYear W20193206252021 @default.
• W2019320625 countsByYear W20193206252022 @default.
• W2019320625 countsByYear W20193206252023 @default.
• W2019320625 crossrefType "journal-article" @default.
• W2019320625 hasAuthorship W2019320625A5001591986 @default.
• W2019320625 hasAuthorship W2019320625A5019816563 @default.
• W2019320625 hasAuthorship W2019320625A5020185605 @default.
• W2019320625 hasAuthorship W2019320625A5024243963 @default.
• W2019320625 hasAuthorship W2019320625A5037128174 @default.
• W2019320625 hasBestOaLocation W20193206251 @default.
• W2019320625 hasConcept C126322002 @default.
• W2019320625 hasConcept C127413603 @default.
• W2019320625 hasConcept C156957248 @default.
• W2019320625 hasConcept C2776042228 @default.
• W2019320625 hasConcept C2777697326 @default.
• W2019320625 hasConcept C2780333948 @default.
• W2019320625 hasConcept C2780645631 @default.
• W2019320625 hasConcept C71924100 @default.
• W2019320625 hasConcept C72563966 @default.
• W2019320625 hasConcept C78519656 @default.
• W2019320625 hasConceptScore W2019320625C126322002 @default.
• W2019320625 hasConceptScore W2019320625C127413603 @default.
• W2019320625 hasConceptScore W2019320625C156957248 @default.
• W2019320625 hasConceptScore W2019320625C2776042228 @default.
• W2019320625 hasConceptScore W2019320625C2777697326 @default.
• W2019320625 hasConceptScore W2019320625C2780333948 @default.
• W2019320625 hasConceptScore W2019320625C2780645631 @default.

• next